Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring. (2026). Canadian Diabetes & Endocrinology Today, 4(1), 10–16. https://doi.org/10.58931/cdet.2026.4150